Insider · CIK 0001891107

Virnich Daniel

Reports to the SEC for 1 company · CERRITOS, CA

sec.gov

Transactions

Companies

Filings

CIK

0001891107

Forms 4 and 5

Insider transactions

37 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-05-21	STLNStarling Oncology, Inc.J Other	Chief Executive Officer	JOther	−23.1K sh	$4.47	−$103K	2,337,166
2026-03-27	STLNStarling Oncology, Inc.A Award	Chief Executive Officer	AAward	−671K sh	—	—	2,458,758
2026-03-27	STLNStarling Oncology, Inc.J Other	Chief Executive Officer	JOther	−98.5K sh	$3.07	−$302K	2,360,224
2026-03-17	STLNStarling Oncology, Inc.J Other	Chief Executive Officer	JOther	−11.8K sh	$3.59	−$42.5K	1,788,150
2025-11-17	STLNStarling Oncology, Inc.A Award	Chief Executive Officer	AAward	+6,464 sh	—	—	1,799,984
2025-11-12	STLNStarling Oncology, Inc.A Award	Chief Executive Officer	AAward	+6,211 sh	—	—	1,793,520
2025-05-21	STLNStarling Oncology, Inc.D Disposition to Issuer	Chief Executive Officer	DDisposition to Issuer	−20.4K sh	$2.67	−$54.5K	1,787,309
2025-03-31	STLNStarling Oncology, Inc.A Award	Chief Executive Officer	AAward	+1.08M sh	—	—	1,807,697
2025-03-26	STLNStarling Oncology, Inc.P Purchase	Chief Executive Officer	PPurchase	+22.6K sh	$1.04	+$23.6K	724,363
2025-03-26	STLNStarling Oncology, Inc. · Common WarrantP Purchase	Chief Executive Officer	PPurchase	+11.3K sh	$0.13	+$1,415	11,320
2025-03-19	STLNStarling Oncology, Inc.D Disposition to Issuer	Chief Executive Officer	DDisposition to Issuer	−10.3K sh	$0.89	−$9,122.029	701,723
2024-11-20	STLNStarling Oncology, Inc.D Disposition to Issuer	Chief Executive Officer	DDisposition to Issuer	−4,750 sh	$0.14	−$646	716,961
2024-11-20	STLNStarling Oncology, Inc.D Disposition to Issuer	Chief Executive Officer	DDisposition to Issuer	−4,977 sh	$0.14	−$676.872	711,984
2024-11-12	STLNStarling Oncology, Inc.J Other	Chief Executive Officer	JOther	−78.1K sh	—	—	838,853
2024-11-12	STLNStarling Oncology, Inc.J Other	Chief Executive Officer	JOther	−117K sh	—	—	721,711
2024-05-21	STLNStarling Oncology, Inc.D Disposition to Issuer	Chief Executive Officer	DDisposition to Issuer	−11.2K sh	$0.60	−$6,672.516	718,430
2024-05-21	STLNStarling Oncology, Inc.A Award	Chief Executive Officer	AAward	+199K sh	—	—	916,947
2024-05-21	STLNStarling Oncology, Inc. · Non-Qualified Stock Option (right to buy)A Award	Chief Executive Officer	AAward	+496K sh	—	—	496,293
2023-11-21	STLNStarling Oncology, Inc.D Disposition to Issuer	Chief Executive Officer	DDisposition to Issuer	−4,322 sh	$2.19	−$9,478.146	729,603
2023-11-14	STLNStarling Oncology, Inc.D Disposition to Issuer	Chief Executive Officer	DDisposition to Issuer	−4,604 sh	$2.38	−$11K	733,925
2023-03-17	STLNStarling Oncology, Inc.A Award	Chief Executive Officer	AAward	+115K sh	—	—	738,529
2023-03-17	STLNStarling Oncology, Inc. · Non-Qualified Stock Option (right to buy)A Award	Chief Executive Officer	AAward	+287K sh	—	—	287,361
2022-12-07	STLNStarling Oncology, Inc.M Exercise/Conversion	Chief Executive Officer	MExercise/Conversion	+175K sh	$0.86	+$151K	448,585
2022-12-07	STLNStarling Oncology, Inc.M Exercise/Conversion	Chief Executive Officer	MExercise/Conversion	+175K sh	$0.86	+$151K	623,585
2022-12-07	STLNStarling Oncology, Inc. · Non-Qualified Stock Option (right to buy)M Exercise/Conversion	Chief Executive Officer	MExercise/Conversion	−175K sh	—	—	829,609
2022-12-07	STLNStarling Oncology, Inc. · Non-Qualified Stock Option (right to buy)M Exercise/Conversion	Chief Executive Officer	MExercise/Conversion	−175K sh	—	—	654,609
2022-11-17	STLNStarling Oncology, Inc.A Award	Chief Executive Officer	AAward	+40.1K sh	—	—	273,585
2022-11-17	STLNStarling Oncology, Inc. · Non-Qualified Stock Option (right to buy)A Award	Chief Executive Officer	AAward	+204K sh	—	—	203,543
2022-11-15	STLNStarling Oncology, Inc.D Disposition to Issuer	Chief Executive Officer	DDisposition to Issuer	−3,767 sh	$2.03	−$7,638.723	233,484
2022-11-15	STLNStarling Oncology, Inc.S Sale	Chief Executive Officer	SSale	−3,767 sh	$2.03	−$7,638.723	233,484
2022-03-21	STLNStarling Oncology, Inc.A Award	Chief Executive Officer	AAward	+42K sh	—	—	237,251
2022-03-21	STLNStarling Oncology, Inc. · Stock Option (right to buy)A Award	Chief Executive Officer	AAward	+34.1K sh	—	—	34,121
2022-03-21	STLNStarling Oncology, Inc. · Stock Option (right to buy)A Award	Chief Executive Officer	AAward	+213K sh	—	—	213,259
2021-11-12	STLNStarling Oncology, Inc.A Award	Chief Executive Officer	AAward	+78.1K sh	—	—	78,094
2021-11-12	STLNStarling Oncology, Inc.A Award	Chief Executive Officer	AAward	+117K sh	—	—	195,236
2021-11-12	STLNStarling Oncology, Inc. · Stock Options (right to buy)A Award	Chief Executive Officer	AAward	+427K sh	—	—	426,603
2021-11-12	STLNStarling Oncology, Inc. · Stock Options (right to buy)A Award	Chief Executive Officer	AAward	+578K sh	—	—	68,208

Recent filings

Accepted (ET)
May 224
Virnich Daniel0001079973-26-000725
SEC(opens sec.gov)
Apr 14
Virnich Daniel0001079973-26-000439
SEC(opens sec.gov)
Mar 184
Virnich Daniel0001079973-26-000332
SEC(opens sec.gov)
Nov 194
Virnich Daniel0001079973-25-001809
SEC(opens sec.gov)
Nov 144
Virnich Daniel0001079973-25-001765
SEC(opens sec.gov)
May 224
Virnich Daniel0001628280-25-027210
SEC(opens sec.gov)
Apr 24
Virnich Daniel0001799191-25-000017
SEC(opens sec.gov)
Mar 284
Virnich Daniel0001079973-25-000529
SEC(opens sec.gov)
Mar 204
Virnich Daniel0001799191-25-000008
SEC(opens sec.gov)
Nov 214
Virnich Daniel0001799191-24-000043
SEC(opens sec.gov)
Nov 184
Virnich Daniel0001799191-24-000033
SEC(opens sec.gov)
May 234
Virnich Daniel0001799191-24-000011
SEC(opens sec.gov)
Nov 224
Virnich Daniel0001628280-23-039911
SEC(opens sec.gov)
Nov 164
Virnich Daniel0001628280-23-039300
SEC(opens sec.gov)

Companies

Starling Oncology, Inc.Chief Executive OfficerSTLN

Address

C/O THE ONCOLOGY INSTITUTE INC. 18000 STUDEBAKER RD, SUITE 800

CERRITOS, CA, 90703